Inventor
GOMEZ-MANCILLA BALTAZAR
US11 patents
⚠️ This page may combine multiple inventors who share the name “GOMEZ-MANCILLA BALTAZAR”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
NOVARTIS AG
6 patentsUS12201612B2Jan 21, 2025
Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol use
NOVARTIS AG1 citations59
US12215387B2Feb 4, 2025
Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
NOVARTIS AG0 citations58
US11359241B2Jun 14, 2022
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
NOVARTIS AG0 citations58
US9828642B2Nov 28, 2017
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
NOVARTIS AG1 citations58
US11878001B2Jan 23, 2024
Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use
NOVARTIS AG1 citations57
US11096916B2Aug 24, 2021
Use of nicotinic acetylcholine receptor alpha 7 activators
NOVARTIS AG0 citations57
UPJOHN CO
3 patentsUS6001861ADec 14, 1999
Use of pramipexole in the treatment of restless legs syndrome
UPJOHN CO36 citations88
US6503920B1Jan 7, 2003
Cabergoline and pramipexole: new uses and combinations
UPJOHN CO6 citations72
US6194445B1Feb 27, 2001
Use of pramipexole in the treatment of restless legs syndrome
UPJOHN CO8 citations69